ICML 2017

Area: Hematology , Oncology

Location: Lugano, Switzerland

Date: June 14 to June 17

Description:

14th International Conference on Malignant Lymphoma.

Search in Scientific Content:
Date
Filters:
PROGNOSTIC
8:05

PROGNOSTIC VALUE OF PET-CT AFTER FIRST-LINE IMMUNOCHEMOTHERAPY FOR FOLLICULAR LYMPHOMA IN THE PHASE III GALLIUM STUDY

Presenter: Judith Trotman
Hematology , Oncology : Lymphoma
Highlights
9:30

Highlights of the congress

Presenter: Franco Cavalli
Hematology , Oncology : Lymphoma
CHALLENGES
15:05

CHALLENGES AND OPPORTUNITIES IN THE MANAGEMENT OF AGGRESSIVE B CELL LYMPHOMAS

Presenter: Stephen J. Schuster
Hematology , Oncology : Lymphoma
IMMUNOTHER
9:15

IMMUNOTHERAPY IN LYMPHOMAS / CHECKPOINT INHIBITORS

Presenter: Stephen Ansell
Hematology , Oncology : Lymphoma
NIVOLUMAB
15:29

NIVOLUMAB FOR RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA AFTER AUTOLOGOUS TRANSPLANT: FULL RESULTS AFTER EXTENDED FOLLOWUP OF THE PHASE 2 CHECKMATE 205 TRIAL

Presenter: Michelle Fanelle
Hematology , Oncology : Lymphoma
IMMUNOCHEM
6:17

IMMUNOCHEMOTHERAPY WITH OBINUTUZUMAB OR RITUXIMAB IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA IN THE RANDOMISED PHASE III GALLIUM STUDY: ANALYSIS BY CHEMOTHERAPY REGIMEN

Presenter: W. Hiddemann
Hematology , Oncology : Lymphoma
Highlights
3:43

Highlights of the congress

Presenter: Julie Vose
Hematology , Oncology : Lymphoma
BENDAMUSTI
9:56

BENDAMUSTINE, FOLLOWED BY OBINUTUZUMAB AND VENETOCLAX IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: CLL2-BAG TRIAL OF THE GERMAN CLL STUDY GROUP (GCLLSG)

Presenter: Paula Cramer
Hematology , Oncology : Lymphoma
Bratislava 2014

Bratislava 2014
2014-10-09 - 2014-10-10
Bratislava, Slovakia
ESMO 2014

ESMO 2014
2014-09-26 - 2014-09-30
Madrid, Spain